Covered recipient · General Payments record
HADY MASRI
Allopathic & Osteopathic Physicians Family Medicine Geriatric Medicine
General Payments · PY2022–2025
$370.83
- Reported across 13 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $292.17 | 9 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corcept Therapeutics | $186.32 | 4 |
| Lilly USA, LLC | $26.95 | 1 |
| Gilead Sciences, Inc. | $22.14 | 1 |
| Merck Sharp & Dohme Corporation | $22.09 | 1 |
| Novo Nordisk AS | $17.78 | 1 |
| Amgen Inc. | $16.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $16.89 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228384558 | CMS |
| Corcept Therapeutics | $14.83 | 01/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214230253 | CMS |
| Corcept Therapeutics | $26.22 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214230297 | CMS |
| Corcept Therapeutics | $21.58 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214230335 | CMS |
| Corcept Therapeutics | $123.69 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214230379 | CMS |
| Gilead Sciences, Inc. | $22.14 | 10/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234503731 | CMS |
| Lilly USA, LLC | $26.95 | 03/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186654499 | CMS |
| Merck Sharp & Dohme LLC | $22.09 | 04/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238137203 | CMS |
| Novo Nordisk Inc | $17.78 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188429034 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.